Tag: FDA guidance 2025
Biosimilar Approval: How the FDA Reviews Biologic Alternatives in 2026
The FDA's 2025 update to biosimilar approval rules is speeding up access to cheaper biologic drugs. Learn how analytical data now replaces costly clinical trials, what interchangeability really means, and why this change could save the U.S. healthcare system billions.
View MoreLatest Posts
